From Profiling to Management: A Systematic Review of The Prevalence, Clinical Profile, and Outcomes in Isolated Systolic Hypertension
DOI:
https://doi.org/10.53366/jimki.v12i1.844Keywords:
hypertension, isolated systolic hypertension, risk factors, target organs, therapyAbstract
Introduction: Isolated Systolic Hypertension (ISH) is a type of hypertension that was initially found mostly in the elderly, although recent studies indicate that it is increasingly common in younger adults. ISH has clinical implications for cardiovascular health and target organs. Limited awareness and management of ISH highlight the urgency of comprehensive studies to deepen understanding.
Method: This study is a systematic review conducted in accordance with the PRISMA 2020 guidelines. Literature was searched from the PubMed, Scopus, and Web of Science databases. Included articles were primary studies with cross-sectional, cohort, RCT, or primary meta-analysis designs published between 2016 and 2025, in English, and available in open access. Risk of bias assessment was conducted using the RoB 2 tool and the Newcastle-Ottawa Scale.
Discussion: A total of 24 articles met the inclusion criteria, covering more than 4 million participants from various age groups. Epidemiological studies indicate a high prevalence of ISH, even among adolescents and young adults. The main risk factors include age, high BMI, insulin resistance, low physical activity, and socioeconomic factors. ISH is associated with various clinical conditions, such as increased left ventricular mass, arterial stiffness, and impaired kidney function. Pharmacological interventions like calcium channel blockers and beta-blockers show varying effectiveness. Non-pharmacological approaches, such as renal denervation, have limited effects on pure ISH.
Conclusion: ISH is a high-risk condition that is widespread across various age groups. Understanding its epidemiology, risk factors, pathophysiology, and response to treatment is important for appropriate therapy and prevention of long-term clinical implications.
References
1. Mahajan S, Feng F, Hu S, Lu Y, Gupta A, Murugiah K, et al. Assessment of Prevalence, Awareness, and Characteristics of Isolated Systolic Hypertension Among Younger and Middle-Aged Adults in China. JAMA Netw Open. 2020;3(12):E209743.
2. Shen Y, Wang P, Yang X, Chen M, Dong Y, Li J. A cross sectional study identifying disparities in serum metabolic profiles among hypertensive patients with ISH, IDH and SDH subtypes. Front Cardiovasc Med [Internet]. 2023 May 4;10. Available from: https://www.frontiersin.org/arti cles/10.3389/fcvm.2023.1102 754/full
3. Hosseinzadeh A, Ebrahimi H, Khosravi A, Emamian MH, Hashemi H, Fotouhi A. Isolated systolic hypertension and its associated risk factors in Iranian middle age and older population: a population-based study. BMC Cardiovasc Disord [Internet]. 2022;22(1):1–8. Available from: https://doi.org/10.1186/s12872-022-02856-7
4. Seryan A, Martin M, Hamimatunnisa J, Annette P, Margit H, Karl-Heinz L. Cardiovascular mortality risk in young adults with isolated systolic hypertension: findings from population-based MONICA/KORA cohort study. J Hum Hypertens. 2022;36(12):1059–65.
5. Jung H, Di Giovanna E, Kim Y, Jun TJ, Kim K. Cardiovascular Outcomes Associated With Isolated Systolic or Diastolic Hypertension According to the 2017 AHA/ACC Guideline in Adult Cancer Survivors. J Am Heart Assoc [Internet]. 2024 Oct;13(19). Available from: https://www.ahajournals.org/d oi/10.1161/JAHA.124.036266
6. Bae EH, Lim SY, Jung J, Oh TR, Choi HS, Kim CS, et al. Chronic Kidney Disease Risk of Isolated Systolic or Diastolic Hypertension in Young Adults: A Nationwide Sample Based Cohort Study. J Am Heart Assoc [Internet]. 2021 Apr 6;10(7). Available from: https://www.ahajournals.org/d oi/10.1161/JAHA.120.019764
7. Eeftinck Schattenkerk DW, van Gorp J, Vogt L, Peters RJ, van den Born BJH. Isolated systolic hypertension of the young and its association with central blood pressure in a large multi-ethnic population. The HELIUS study. Eur J Prev Cardiol [Internet]. 2018 Sep 29;25(13):1351–9. Available from: https://academic.oup.com/eurj pc/article/25/13/1351 1359/5926227
8. Gu Q, Meng J, Hu X, Ge J, Wang SJ, Liu XZ. Isolated systolic hypertension and insulin resistance assessment tools in young and middle aged Chinese men with normal fasting glucose: a cross sectional study. [Internet]. Sci Rep 2022;12(1):1–9. Available from: https://doi.org/10.1038/s41598-021-04763-x
9. Huang X, Qiu L, Wang T, Yao Q, Liu J, Xu R, et al. Prevalence and risk factors for isolated systolic hypertension among the oldest‐old population in southwestern China: A community‐based cross‐sectional study. J Clin Hypertens [Internet]. 2024 Jul 30;26(7):757–64. Available from: https://onlinelibrary.wiley.com/ doi/10.1111/jch.14826
10. Xie K, Gao X, Bao L, Shan Y, Shi H, Li Y. The different risk factors for isolated diastolic hypertension and isolated systolic hypertension: a national survey. BMC Public Health [Internet]. 2021 Dec 14;21(1):1672. Available from: https://bmcpublichealth.biome dcentral.com/articles/10.1186/ s12889-021-11686-9
11. Wang SY, Hanna JM, Gongal P, Onuma OK, Nanna MG. Choice of antihypertensive agent in isolated systolic hypertension and isolated diastolic hypertension: A secondary analysis of the ALLHAT trial. Am Heart J [Internet]. 2022 Dec;254:30–4. Available from: https://linkinghub.elsevier.com /retrieve/pii/S0002870322001 570
12. Tanially E, Sukinata WN, Kurniawan A. Comparative Efficacy of Nebivolol Versus Atenolol for the Treatment of Isolated Systolic Hypertension: A Systematic Review. J Hypertens [Internet]. 2025 May;43(Suppl 2):e4. Available from: https://journals.lww.com/10.10 97/01.hjh.0001118536.23891.
13. LI L, XIONG YL, TU B, LIU SY, renal ZHANG ZH, HU Z, et al. Effect of denervation for patients with isolated systolic hypertension: a systematic review and meta-analysis. J Geriatr Cardiol [Internet]. 2023 Feb;20(2):121–9. Available from: https://www.sciopen.com/articl e/10.26599/1671 5411.2023.02.003
14. Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ [Internet]. 2019 Aug 28;l4898. Available from: https://www.bmj.com/lookup/d oi/10.1136/bmj.l4898
15. Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M TP. The Newcastle–Ottawa Scale (NOS) for assessing the quality of studies [Internet]. Research Available in nonrandomised meta-analyses Ottawa Hospital Institute. 2000. from: http://www.ohri.ca/programs/cl inical_epidemiology/oxford.as p
16. Wang C, Liu S, Miao W, Ye N, Xie Z, Qiao L, et al. Intensive blood pressure control in isolated systolic hypertension: a post hoc analysis of a cluster randomized trial. Lancet Reg Heal - West Pacific [Internet]. 2024;48:101127. Available from: https://doi.org/10.1016/j.lanwp c.2024.101127
17. Sarnecki J, Obrycki Ł, Feber J, Chełstowska S, Jurkiewicz E, Litwin M. Isolated systolic hypertension is associated with increased left ventricular mass index and aortic stiffness in adolescents: a cardiac magnetic resonance study. J Hypertens [Internet]. 2022 May;40(5):985–95. Available from: 18. 19. 20. 21. https://journals.lww.com/10.10 97/HJH.0000000000003101
18. Asmare DS, Abebe TA, Miskir M, Ashenef B, Adugna A, Muche Y, et al. Magnitude and determinants of isolated systolic hypertension among type 2 diabetes patients in selected referral hospitals in Amhara Region, Ethiopia. Sci Rep [Internet]. 2025 Apr 10;15(1):12221. Available from: https://www.nature.com/article s/s41598-025-97578-z
19. Hao Y, Li X, Zhu Y, Ke J, Lou T, Li M, et al. Effect of age and isolated systolic or diastolic hypertension on target organ damage in non-dialysis patients with chronic kidney disease. Aging (Albany NY) [Internet]. 2021 Feb 28;13(4):6144–55. Available from: https://www.aging us.com/lookup/doi/10.18632/a ging.202609
20. Espeche W, Minetto J, Stavile N, Cerri G, C Leiva S, D O, et al. Isolated systolic hypertension in young adults and its relationship with ambulatory blood pressure measurements. Arch Clin Hypertens. 2024;10(1):001–6.
21. Dagnew B, Yeshaw Y. Predictors of isolated systolic hypertension among type 2 diabetes mellitus patients in Jimma University Specialized Hospital, Southwest Ethiopia. BMC Res Notes [Internet]. 2019 Dec Available 15;12(1):510. from: https://bmcresnotes.biomedce ntral.com/articles/10.1186/s13 104-019-4550-3 22.
22. Obrycki Ł, Feber J, Brzezińska G, Litwin M. Evolution of isolated systolic hypertension with normal central blood pressure in adolescents— prospective study. Pediatr Nephrol [Internet]. 2021 Feb 3;36(2):361–71. Available from: https://link.springer.com/10.10 07/s00467-020-04731-z
23. Chuang S, Chang H, Tsai T, Cheng H, Pan W, Chen C. Isolated systolic hypertension and central blood pressure: Implications from the national nutrition and health survey in Taiwan. J Clin Hypertens [Internet]. 2021 22;23(3):656–64. from: Mar Available https://onlinelibrary.wiley.com/ doi/10.1111/jch.14105
24. Citoni B, Figliuzzi I, Presta V, Cesario V, Miceli F, Bianchi F, et al. Prevalence and clinical characteristics of isolated systolic hypertension in young: analysis of 24 h ambulatory blood pressure monitoring database. J Hum Hypertens [Internet]. 2022 15;36(1):40–50. from: Jan Available https://www.nature.com/article s/s41371-021-00493-9
25. Brunström M, Carlberg B, Kjeldsen SE. Effect of antihypertensive treatment in isolated systolic hypertension (ISH)–systematic review and meta-analysis of randomised controlled trials. Blood Press 73 [Internet]. 2023;32(1). Available from: https://doi.org/10.1080/08037 051.2023.2226757
26. Kibria GM Al. Prevalence and Trends of Isolated Systolic Hypertension among Untreated Older People in the US according to the 2017 ACC/AHA Guideline, 2001–16. J Hum Hypertens [Internet]. 2021 Jan 12;35(1):101–3. Available from: https://www.nature.com/article s/s41371-020-0351-3
27. Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et al. Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association. Circulation [Internet]. 2023 Feb 21;147(8). Available from: https://www.ahajournals.org/d oi/10.1161/CIR.00000000000 01123 28.
28. Mahajan S, Feng F, Hu S, Lu Y, Gupta A, Murugiah K, et al. Assessment of Prevalence, Awareness, and Characteristics of Isolated Systolic Hypertension Among Younger and Middle-Aged Adults in China. JAMA Netw Open [Internet]. 2020 Dec 8;3(12):e209743. Available from: https://jamanetwork.com/journ als/jamanetworkopen/fullarticl e/2773814 29.
29. Ohishi M. Hypertension with diabetes mellitus: physiology and pathology. Hypertens Res [Internet]. 2018 Jun 19;41(6):389–93. Available from: https://www.nature.com/article s/s41440-018-0034-4 30.
30. Zamolodchikova TS, Tolpygo SM, Kotov A V. Insulin in the regulation of the renin angiotensin system: a new perspective on the mechanism of insulin resistance and diabetic complications. Front Endocrinol (Lausanne) [Internet]. 2024 Jan 23;15. Available from: https://www.frontiersin.org/arti cles/10.3389/fendo.2024.1293 221/full
31. Castelli R, Gidaro A, Casu G, Merella P, Profili NI, Donadoni M, et al. Aging of the Arterial System. Int J Mol Sci [Internet]. 2023 Apr 7;24(8):6910. Available from: https://www.mdpi.com/1422 0067/24/8/6910
32. Schillaci G, Pucci G. Aging and pulse pressure widening. J Hypertens [Internet]. 2015 Dec;33(12):2389–91. Available from: https://journals.lww.com/0000 4872-201512000-00004
33. Radchenko G, Torbas O, Sirenko Y. Predictors of high central blood pressure in young with isolated systolic hypertension. Vasc Health Risk Manag [Internet]. 2016 Aug;Volume 12:321–8. Available from: https://www.dovepress.com/pr edictors-of-high-central-blood pressure-in-young-with isolated-systo-peer-reviewed article-VHRM
Additional Files
Published
Issue
Section
License
Copyright (c) 2025 Ainun Ni'mah Syawaliyah, Naura Alifa Khairunnisa
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.